1057377--4/14/2008--SAMARITAN_PHARMACEUTICALS

related topics

{product, liability, claim}

{stock, price, share}

{property, intellectual, protect}

{product, candidate, development}

{interest, director, officer}

{acquisition, growth, future}

{product, market, service}

{regulation, change, law}

{control, financial, internal}

{personnel, key, retain}

{provision, law, control}

RISKS ASSOCIATED WITH OUR BUSINESS We Have A Limited Operating History With Significant Losses And Expect Losses To Continue In The Near Future We Will Need Additional Capital In The Future, But Our Access To Such Capital Is Uncertain. Our Independent Registered Public Accounting Firm Has Issued An Unqualified Opinion With An Explanatory Paragraph, To The Effect That There Is Substantial Doubt About Our Ability To Continue As A Going Concern. If We Do Not Receive And Maintain Regulatory Approvals For Our Products Or Product Candidates, We Will Not Be Able To Commercialize Our Products, Which Would Substantially Impair Our Ability To Generate Revenues And Materially Harm Our Business And Financial Condition. If Our Products Do Not Gain Market Acceptance, Our Business Will Suffer Because We Might Not Be Able To Fund Future Operations. If We Fail To Properly Manage Our Anticipated Growth, Our Business Could Suffer. The Company's License Agreements May Be Terminated In The Event Of A Breach Protecting Our Proprietary Rights Is Difficult and Costly The Company's Success Will Be Dependent Upon The Licenses And Proprietary Rights It Receives From Other Parties, And On Any Patents It May Obtain We Are Faced With Intense Competition And Industry Changes, Which May Make It More Difficult For Us To Achieve Significant Market Penetration. If We Are Unable To Continue Product Development, Our Business Will Suffer There Is No Assurance That Our Products Will Have Market Acceptance There Is Uncertainty Relating To Third-Party Reimbursement, Which Is Critical To Market Acceptance Of Our Products. If We Are Unable To Protect Our Intellectual Property, We May Not Be Able To Operate Our Business Profitably If We Are Unable To Operate Our Business Without Infringing Upon The Intellectual Property Rights Of Others, We May Not Be Able To Operate Our Business Profitably. If We Become Subject To Product Liability Claims, We May Be Required To Pay Damages That Exceed Our Insurance Coverage. Insurance Coverage Is Increasingly More Difficult To Obtain or Maintain Our Success Will Depend On Our Ability To Attract And Retain Key Personnel We Are Dependent On Third Parties For A Significant Portion Of Our Bulk Supply And The Formulation, Fill And Finish Of Our Product Candidates. Our Corporate Compliance Program Cannot Guarantee That We Are In Compliance With All Potentially Applicable U.S. Federal And State Regulations And All Potentially Applicable Foreign Regulations. RISKS ASSOCIATED WITH AN INVESTMENT IN OUR COMMON STOCK Our Stock Is Currently Listed On The OTC Bulletin Board Which Limits The Trading Of Our Stock A Sale Of A Substantial Number Of Shares Of Our Common Stock May Cause The Price Of Our Common Stock To Decline. Because We Do Not Intend To Pay Dividends, You Will Benefit From An Investment In Our Common Stock Only If It Appreciates In Value. The Market Price Of Our Common Stock Is Highly Volatile. Under Provisions Of The Company's Articles Of Incorporation, Bylaws And Nevada Law, The Company's Management May Be Able To Block Or Impede A Change In Control Officers and Directors Liabilities Are Limited Under Nevada Law

Full 10-K form ▸

1057377--4/14/2008--SAMARITAN_PHARMACEUTICALS_INC